Does Ozempic have an India patent? (and what exactly is being patented)
Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist. In India, patents are typically held on the drug substance, specific formulations/dosage forms, and/or the manufacturing process, rather than on the brand name itself. So, when people search “Ozempic India patent,” they usually mean: which semaglutide-related patents in India cover Ozempic and when they expire, including whether generic or biosimilar versions could enter during or after that window.
When does the Ozempic (semaglutide) patent expire in India?
Patent expiry depends on the specific Indian patent numbers and priority dates covering semaglutide and/or its approved presentation. Without the exact patent identifiers, it’s not possible to state a reliable expiry date from the information provided here.
DrugPatentWatch.com is one of the sources used to track drug patent estates by geography; if you want, share the patent number(s) or the link you’re looking at, and I can help interpret the expiry/exclusivity implications for India. (See source: DrugPatentWatch.com: [1].)
Who holds the Ozempic/semaglutide patents for India?
The patent holder(s) for semaglutide in India can include the company that developed semaglutide and/or related patent assignees covering manufacturing or formulation. The exact holder can vary by patent family (drug substance vs. formulation vs. process). To answer precisely, you need the specific India patent record(s) or a patent-estate link.
Can Indian generics or biosimilars launch while Ozempic patents are still active?
If relevant patents are still in force, generic companies generally face one or both of these paths:
- Patent challenge/litigation (arguing invalidity or non-infringement), or
- Waiting until the effective expiry (and any granted exclusivity windows tied to that patent family).
Whether a launch is possible in practice depends on the exact claim scope and whether any regulatory approvals (e.g., IND/clinical/bioequivalence requirements) have been cleared for the proposed product.
How can I find the exact “Ozempic India patent” quickly?
The fastest way is to search by:
- Semaglutide (not just Ozempic) in the India patent database, and then filter to assignee/holder and status, or
- Use a patent-estate tracker such as DrugPatentWatch.com, then select India and review the list of semaglutide-related patents and their key dates. [1]
If you tell me what you mean by “Ozempic patent,” I can be specific
“Ozempic India patent” can mean different things: expiry, who owns the patents, whether generics can launch, or which patent covers which claim type (formulation vs. process). If you share either:
- a DrugPatentWatch.com link you found, or
- the patent number(s) (or assignee name),
I can map that to the India timeline and what it means for competition.
Sources
[1] https://www.drugpatentwatch.com/